Author

Marie Amalie Müller

Institutions: University of Copenhagen, Novo Nordisk Foundation, Novo Nordisk Foundation Center for Basic Metabolic Research

Observed institutions: University of Copenhagen, Novo Nordisk Foundation, Novo Nordisk Foundation Center for Basic Metabolic Research

OpenAlex ID: A5140205458

Preventative semaglutide and tirzepatide treatment does not alter disease progression in the 5xFAD mouse model of Alzheimer's disease

2026 · Anika Vear, Sofie Amalie Olsen, et al. · Cell Reports Medicine · 2

Works count: 1

Citation count: 2

H-index: 1

I10-index: